Liao Bo, Liu Junbo, Chen Shuangquan, Zhang Qiang, Xie Chaofan, Jiang Guo, Cui Shu, Wu Tao
Department of Urology, Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, Sichuan, P.R. China.
Urol J. 2019 Oct 21;16(5):417-426. doi: 10.22037/uj.v0i0.5095.
This study reviewed the efficacy and safety of the microsurgical subinguinal varicocelectomy (MSV) with and without testicular delivery (TD) for varicocele patients.
A systematic literature search was conducted in EMBASE, PubMed, MEDLINE, Cochrane databases, China National Knowledge Infrastructure (CNKI), Chinese Biomedical Literature Database (CBM), and Google Scholar databases to identify relevant studies that reported MSV with and without TD for varicocele patients published in English or Chinese up to October 2018. The Newcastle-Ottawa Scale (NOS) and the Jadad scores were used to evaluate the methodological quality of all the included studies. We also used the Cochrane Collaboration's tool for assessing risk of bias for each study. The Review Manager Software version 5.3 was used to conduct data analysis.
Four RCTs and three retrospective studies consisting of 993 patients were included. Meta-analysis results indicated that both of the two treatments were effective and safe. MSV with TD had a lower recurrence rate (OR = 0.20, 95% CI: 0.06 - 0.65, P = .007, I2 = 0%) and postoperative serum testosterone level (MD = -39.07, 95% CI: -51.95 - -26.18, P = .00001, I2 = 0%) compared with MSV without TD but was associated with higher postopera-tive complications rate (OR=7.35, 95% CI: 2.92-18.53, P < .0001, I2 = 0%). We found no significant differences in operation time (MD = 12.46, 95% CI:0.11-24.81,P= .05, I2 = 87%), sperm concentration (MD = 3.73, 95% CI: -2.88 - 10.35, P = .27, I2 = 81%), sperm motility (MD = 10.96, 95% CI: -11.93 - 33.86, P = .35, I2 = 99%), and pregnancy rate(OR = 0.65, 95% CI: 0.37- 1.16, P = .15, I2 = 0%).
This meta-analysis compared efficacy and safety of MSV with and without TD for varicocele pa-tients. MSV with TD was associated with a higher postoperative complication rate but lower recurrence rate and postoperative serum testosterone level than MSV without TD. In terms of preoperative serum testosterone level, operation time, sperm concentration, sperm motility, and pregnancy rate, we found no significant differences.
本研究回顾了采用和不采用睾丸牵引(TD)的显微外科腹股沟下精索静脉结扎术(MSV)治疗精索静脉曲张患者的疗效和安全性。
在EMBASE、PubMed、MEDLINE、Cochrane数据库、中国知网(CNKI)、中国生物医学文献数据库(CBM)和谷歌学术数据库中进行系统的文献检索,以识别截至2018年10月发表的用英文或中文报道的采用和不采用TD的MSV治疗精索静脉曲张患者的相关研究。采用纽卡斯尔-渥太华量表(NOS)和Jadad评分来评估所有纳入研究的方法学质量。我们还使用Cochrane协作网的工具来评估每项研究的偏倚风险。使用Review Manager软件5.3版进行数据分析。
纳入了4项随机对照试验和3项回顾性研究,共993例患者。荟萃分析结果表明,两种治疗方法均有效且安全。与不采用TD的MSV相比,采用TD的MSV复发率更低(OR = 0.20,95%CI:0.06 - 0.65,P = .007,I² = 0%),术后血清睾酮水平更低(MD = -39.07,95%CI:-51.95 - -26.18,P = .00001,I² = 0%),但术后并发症发生率更高(OR = 7.35,95%CI:2.92 - 18.53,P < .0001,I² = 0%)。我们发现手术时间(MD = 12.46,95%CI:0.11 - 24.81,P = .05,I² = 87%)、精子浓度(MD = 3.73,95%CI:-2.88 - 10.35,P = .27,I² = 81%)、精子活力(MD = 10.96,95%CI:-11.93 - 33.86,P = .35,I² = 99%)和妊娠率(OR = 0.65,95%CI:0.37 - 1.16,P = .15,I² = 0%)无显著差异。
本荟萃分析比较了采用和不采用TD的MSV治疗精索静脉曲张患者的疗效和安全性。与不采用TD的MSV相比,采用TD的MSV术后并发症发生率更高,但复发率和术后血清睾酮水平更低。在术前血清睾酮水平、手术时间、精子浓度、精子活力和妊娠率方面,我们未发现显著差异。